U.S., May 28 -- ClinicalTrials.gov registry received information related to the study (NCT07608705) titled 'A Study to Assess the Effect of HRS-1301 on the Pharmacokinetics of Midazolam and Atorvastatin in Healthy Participants' on May 20.
Brief Summary: This phase I study in healthy participants aims to assess the pharmacokinetics of midazolam and atorvastatin when administered alone and in combination with HRS-1301, and to assess the safety of HRS-1301 when administered alone and in combination with midazolam or atorvastatin.
Study Start Date: June, 2026
Study Type: INTERVENTIONAL
Condition:
Hyperlipidemias
Intervention:
DRUG: HRS-1301 Tablets
HRS-1301 tablets.
DRUG: Atorvastatin Calcium Tablets
Atorvastatin Calcium tablets.
DRU...